U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458880) titled 'Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control' on March 04.
Brief Summary: Intracerebral hemorrhage (ICH) is the second most common form of stroke, with an incidence of around 3000 cases per year in Hong Kong. Although it only accounts for around 20-30% of all strokes, ICH is the most severe form of stroke, contributing to 50% of all stroke mortality and the greatest disability burden in stroke. For those who survive their ICH, they are at high risk of ICH recurrence, stroke, cardiovascular event and death. Hence, reducing these risks after ICH is a top priority to lessen the disease's...